Sponsor pipeline

Ningbo No. 1 Hospital clinical trial pipeline

Get alerts when Ningbo No. 1 Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Not charted: 9 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1
NCT05659628 CD19 CAR-T Expressing IL-7 and CCL19 Combined With Anti-PD1 in RR-DLBCL Diffuse Large B-cell Lymphoma Recruiting 2022-12-21
Not applicable
NCT06987760 Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary… Ureter Injury Recruiting 2025-05-23
NCT07713953 Pre-procedural Risk Score-Based Endoscopist Assignment for Pain Reduction in Unsedated… Colonoscopy Pain Not Yet Recruiting 2026-07-20
NCT06905795 Screening and Intervention of MASLD in Children MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease Active, Not Recruiting 2026-01-12
NCT07181759 Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone Urolithiasis, Calcium Oxalate Not Yet Recruiting 2025-09-18
NCT05482165 Optimizing Intervention Effects in Children and Adolescents Childhood Obesity Active, Not Recruiting 2025-07-09
NCT05482191 Healthy Weight Management Project for Overweight and Obesity Children Obesity Active, Not Recruiting 2025-07-09
NCT06664957 Vitamin C's Antioxidant Effects and COPD Prognosis COPD (Chronic Obstructive Pulmonary Disease) Not Yet Recruiting 2024-12-17
Not specified
NCT06984510 Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD… Type 2 Diabetes Mellitus (T2DM) Recruiting 2025-06-04
NCT07001865 Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia Metabolic Dysfunction-Associated Steatotic Liver Disease Enrolling by Invitation 2025-06-03

Disease areas by active trials

NASH / MASH (3) · Obesity (3) · COPD (1) · Diabetes (1) · DLBCL (1) · Non-Hodgkin Lymphoma (1) · Type 2 Diabetes (1)

Get alerts when Ningbo No. 1 Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free